UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. ___2_____)*
ARRYTHMIA RESEARCH TECHNOLOGIES, INC.
(Name of Issuer)
Common Stock, Par Value $ .01
(Title of Class of Securities)
042698308
(CUSIP Number)
Chambers Medical Foundation
Edwin K. Hunter, Trustee
1807 Lake Street
Lake Charles, LA 70601
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
March 13, 2007
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¬
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
| | | | |
| | | | | |
| CUSIP No. 042698308 | | 13D | | Page 2 of 5 Pages |
| | | | | |
|
| | | | | |
| | | | | |
| 1 |
| | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Chambers Medical Foundation: 72-6134893 | | |
| 2 |
| | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¬ (b) ¬ | | |
| 3 |
| | SEC USE ONLY | | |
| 4 |
| | SOURCE OF FUNDS (see instructions) OO | | |
| 5 |
| | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¬ | | |
| 6 |
| | CITIZENSHIP OR PLACE OF ORGANIZATION State of Louisiana, USA | | |
|
| | | | | |
| | | | | |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | | 7 |
| | SOLE VOTING POWER 276,268 |
| | 8 |
| | SHARED VOTING POWER |
| | 9 |
| | SOLE DISPOSITIVE POWER 276,268 |
| | 10 |
| | SHARED DISPOSITIVE POWER |
|
| | | | | |
| | | | | |
| 11 |
| | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
276,268 | | |
| 12 |
| | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) ¬ | | |
| 13 |
| | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.90% | | |
| 14 |
| | TYPE OF REPORTING PERSON (see instructions)
OO | | |
CUSIP NO. 042698308 SCHEDULE 13D Page 3 of 5
Item 1. Security and Issuer
This statement relates to the $.01 Par Value Common Stock (“Common Stock”) of Arrhythmia Research Technology, Inc. (“HRT”), the principal executive offices of which are located at 25 Sawyer Passway, Fitchburg, Massachusetts 01420.
Item 2. Identity and Background
| |
(a) | Chambers Medical Foundation is a private foundation organized in the form of a charitable trust under the laws of the State of Louisiana. Chambers Medical Foundation received its IRS determination letter recognizing it as an exempt organization under Section 501(c)(3) of the Internal Revenue Code on October 30, 1990. |
| |
(b) | Chambers Medical Foundation's principal office is located at 1807 Lake Street, Lake Charles, Louisiana 70601. |
| |
(c) | Chambers Medical Foundation's principal business is providing grants for medical research. |
| |
(d) | Chambers Medical Foundation has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction during the last five years and was not and is not, as a result of such proceeding, subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
| |
(e) | Chambers Medical Foundation is administered by Edwin K. Hunter and Jason R. Chambers, Co-Trustees. Jason R. Chambers became Co-Trustee on September 6, 2011, however, Jason R. Chambers does not participate in investment decisions pertaining to the HRT stock including the voting of the shares and their disposition. Edwin K. Hunter is solely responsible for all decisions related to the HRT stock owned by the Foundation. |
| |
(i) | Edwin K. Hunter's address is 6126 East Azalea, Lake Charles, Louisiana 70605. |
| |
(ii) | Edwin K. Hunter's principal occupation is his law practice. |
| |
(iii) | Edwin K. Hunter has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years. |
| |
(iv) | Edwin K. Hunter has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction during the last five years and was not and is not, as a result of such proceeding, subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
| |
(v) | Edwin K. Hunter is a citizen of the United States. |
| |
(vi) | Jason R. Chambers' address is 222 12th Street, Suite 1906, Atlanta, Georgia 30309. |
| |
(vii) | Jason R. Chambers' principal occupation is bottled water manufacturing and distribution business. . |
| |
(viii) | Jason R. Chambers has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years. |
CUSIP NO. 042698308 SCHEDULE 13D Page 4 of 5
| |
| (ix) | Jason R. Chambers has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction during the last five years and was not and is not, as a result of such proceeding, subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws. |
(x) Jason R. Chambers is a citizen of the United States.
(xi) Jason R. Chambers is a Director of HRT
Item 3. Source and Amount of Funds or Other Consideration
Chambers Medical Foundation acquired the Common Stock of HRT as a result of the death of Dr. Russell C. Chambers. The Common Stock of HRT for which this reporting is made was held in CSFB IRA #215-142860 for the benefit of Dr. Russell C. Chambers. Chambers Medical Foundation was the designated beneficiary of the IRA.
Item 4. Purpose of Transaction.
Chambers Medical Foundation acquired the Common Stock of HRT as beneficiary of Dr. Chambers' IRA. Chambers Medical Foundation holds the stock for investment purposes. Chambers Medical Foundation has no present plan or proposal with respect to any action that would relate to or result in:
(i) The acquisition by any person of additional securities of HRT, or the disposition of securities of HRT; (ii) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving HRT or its subsidiaries; (iii) a sale or transfer of a material amount of assets of HRT or its subsidiary; (iv) any change in the present board of directors of HRT or management of HRT; (v) any material change in the present capitalization or dividend policy of HRT; (vi) any material change in HRT's business or corporate structure; (vii) any change in HRT's certificate of incorporation or bylaws, or other action which may impede the acquisition of control of HRT by any person; (viii) causing a class of securities of HRT to be delisted from a national securities exchange; (ix) a class of equity securities of HRT becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended; or (x) any action similar to any of the foregoing. Chambers Medical Foundation reserves the right to formulate specific plans or proposals with respect to, or to change its intentions regarding, any or all of the foregoing.
Item 5. Interest in Securities of the Issuer
The aggregate number of shares of Common Stock of HRT beneficially owned by Chambers Medical Foundation and the percentage which those shares are of the outstanding Common Stock of HRT are as follows:
(a) Chambers Medical Foundation 276,268 9.90%
(b) Chambers Medical Foundation has the sole power to vote and the sole power to dispose or direct the disposition of all of the shares of Common Stock listed in subpart (a) of this Item.
(c) The following transactions in Common Stock of HRT were effected by Chambers Medical Foundation since the last Schedule 13D filing:
CUSIP NO. 042698308 SCHEDULE 13D Page 5 of 5
Date Amount of Securities Price/Share Where and How Effected
03/13/07 5,000 $21.0508 Sold on Open Market
03/15/07 5,500 $21.0645 Sold on Open Market
03/19/07 1,716 $22.8478 Sold on Open Market
Item 6. Contracts, Arrangements, Understanding or Relationships with Respect to Securities of the Issuer
Chambers Medical Foundation does not have any contracts, arrangements, understandings, or relationships (legal or otherwise) with any persons with respect to any securities of HRT, including but not limited to transfer or voting of any securities of HRT; finder's fees; joint ventures; loan or option arrangements; puts or calls; guarantees of profits; divisions of profits or losses; or the giving or withholding of proxies.
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct
CHAMBERS MEDICAL FOUNDATION
Date: September 21, 2011 By:_______________________________
Edwin K. Hunter, Co-Trustee
By: ______________________________
Jason R. Chambers, Co-Trustee
